Norsk Hydro: Hydro: Mandatory notification of trade by primary insider

March 25, 2025

Member of the Board of Directors in Norsk Hydro ASA, Jane Toogood, has on March 25, 2025, bought 1,000 shares in Hydro at GBP 4.95 per share. New holding is 1,000 shares.

Investor contact:
Martine Rambøl Hagen
+47 91708918
[email protected]

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments

KRT-1500 Jane Toogood_1
KRT-1500 Jane Toogood_2

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Director/PDMR Shareholding

WithSecure Corporation: SHARE REPURCHASE 25.3.2025

Norsk Hydro: Hydro: Mandatory notification of trade by primary insider

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025...

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

Topics

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025...

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market

Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Global Water Announces Proposed Public Offering of Common Stock

Related Articles

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025...

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

Company

Headlines

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025...

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Newsletter